Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

6.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

6.4K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.3K
No description available
2.3K
Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.9K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.9K
Epigenetic Regulation01:37

Epigenetic Regulation

4.2K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.2K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

PRC2 loss impairs small cell lung cancer tumorigenesis and enhances sensitivity to G9a/GLP inhibition.

Communications biology·2026
Same author

Targeting the reprogrammed metabolism in H3.3K27M pediatric high-grade gliomas.

Biochimica et biophysica acta. Molecular basis of disease·2024
Same author

Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma.

British journal of cancer·2024
Same author

Retinoids and EZH2 inhibitors cooperate to orchestrate anti-oncogenic effects on bladder cancer cells.

Cancer gene therapy·2024
Same author

Combined Inhibition of EZH2 and FGFR is Synergistic in BAP1-deficient Malignant Mesothelioma.

Cancer research communications·2023
Same author

Genetic screens reveal new targetable vulnerabilities in BAP1-deficient mesothelioma.

Cell reports. Medicine·2023

関連する実験動画

Updated: Mar 31, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.6K

幹細胞と癌;ポリコンブ結合

Merel E Valk-Lingbeek1, Sophia W M Bruggeman, Maarten van Lohuizen

  • 1The Netherlands Cancer Institute, Department of Molecular Genetics, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

Cell
|August 19, 2004
PubMed
まとめ

ポリコンブ群 (PcG) タンパク質は,幹細胞の維持と癌の発生に不可欠な表遺伝子調節因子である. 幹細胞の運命を決める幹細胞の役割を理解することは,がん研究と幹細胞療法にとって不可欠です.

科学分野:

  • エピジェネティクス エピジェネティクス
  • 幹細胞生物学 幹細胞生物学
  • 癌生物学 癌生物学について

背景:

  • ポリコンブ群 (PcG) プロテインは,重要なエピジェネティッククロマチンの変形剤である.
  • これらのタンパク質は,胚性および成人の幹細胞の維持に重要な役割を果たします.
  • PcGタンパク質の調節不良は,がんの発症に関与している.

研究 の 目的:

  • 幹細胞の運命を決定するPcGタンパク質の役割を調査する.
  • 幹細胞回路とがんのつながりを理解する.
  • 癌治療における幹細胞の治療の可能性を強調する.

主な方法:

  • この研究は,PcGタンパク質の調節機能に焦点を当てています.
  • それは,幹細胞の運命を制御する外在的および内在的要因を調査します.
  • この研究は,幹細胞生物学とがんのメカニズムを結びつけています.

主要な成果:

  • PcGタンパク質は,幹細胞の維持に不可欠です.
  • 異常なPcG活動は腫瘍発生に寄与する.
  • 腫瘍内の幹細胞は,正常な幹細胞と制御経路を共有しています.

さらに関連する動画

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.8K
Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on: May 11, 2016

9.1K

関連する実験動画

Last Updated: Mar 31, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.6K
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.8K
Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on: May 11, 2016

9.1K

結論:

  • 幹細胞におけるPcGタンパク質の機能を理解することは,がん治療において極めて重要です.
  • 幹細胞回路をターゲットにすることで,がん治療の新たな道を開く可能性がある.
  • 治療的な応用のために,幹細胞の運命を調節するさらなる研究が必要である.